Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The success of a COVID-19 vaccine depends on effective scientific communication

Austin A. Barr
Conditions
August 12, 2020
Share
Tweet
Share

One commonality amongst all reporting associated with the COVID-19 pandemic: “unprecedented.” Unprecedented circumstances, unprecedented symptomatology, unprecedented prevalence, and now, unprecedented velocity. “300 million doses of a safe, effective vaccine for COVID-19 by January 2021”—the project: Operation Warp Speed.

On January 20, 2020, the first case of COVID-19 was reported in the United States; fast forward to July 2020 and the National Institutes of Health announced the start of a Phase 3 clinical trial, evaluating the efficacy of an investigational vaccine for the novel coronavirus.

As we approach a prospective approval, Operation Warp Speed’s once elusive target appears tangible. Despite what many would describe as an extraordinary feat of science, the vaccine candidates have not been met with a congruous response from the public. Why is that?

Recent polls have indicated that less than 50 percent of people in the U.S. would willingly receive a COVID-19 vaccine. For perspective, Dr. Anthony Fauci told CNN that even if two-thirds of the U.S. population were inoculated, it would still fail to provide herd immunity. Previous vaccine development timescales are measured in durations magnitudes larger than mere months. When vaccines which took 15 to 20 years to develop are met with contempt, what will those same individuals say about this vaccine? In fact, what sensible individual would not question the legitimacy of a vaccine under a development process touted to be traveling at superluminal velocity?

If our goal is to ensure the public will be comfortable being inoculated once a safe and effective vaccine is approved, we need to adjust our narrative; otherwise, we should not be surprised when individuals, who under normal circumstances advocate for vaccination, are hesitant to get vaccinated. Furthermore, if we fail to demonstrate the validity of the stringent regulatory standards associated with vaccine development, we may lose the public’s confidence in vaccines for other preventable diseases. We cannot have poor scientific communication undermine the countless efforts which have sought to vanquish anti-vaccination movements.

COVID-19 is not the first coronavirus we have dealt with; its predecessor SARS and its distant relative MERS have been largely eradicated. Various, previously developed, vaccines have rendered many communicable diseases nearly inexistent; for instance, since 1979, after widespread use of the polio vaccine, the U.S. has been polio-free, and the introduction of a measles vaccine has led to a greater than 99 percent reduction in cases. Once contextualized, our circumstances seem far less unprecedented.

In fact, the most unprecedented circumstance we are witnessing is the enormity of resources, researchers, and financial capital poured into the vaccine development process. Not to mention the number of vaccine candidates concomitantly under development—26 candidates in clinical evaluation and 139 candidates in preclinical evaluation. These factors are all at play and should be a larger part of the conversation when we discuss how traditional timelines have been shortened.

It is important to note that this shift in narrative is not with any intention of misinforming or misguiding the public. It is imperative that everyone is aware of any vaccine’s associated risks. However, our enamor—as a scientific community—at the speed of innovation we are witnessing, should not cloud our ability to appropriately communicate with the public. And while we may be unable to instill confidence in everyone, the stakes are much larger than the public’s uptake of this single vaccine.

Perhaps our first step should be to rename a vaccine development project to something more reassuring than a reference to a science-fiction movie.

Austin A. Barr is an undergraduate student.

Image credit: Shutterstock.com

Prev

We need rapid tests for a fast virus

August 12, 2020 Kevin 1
…
Next

Coronavirus exposes income-driven health inequality [PODCAST]

August 12, 2020 Kevin 0
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
We need rapid tests for a fast virus
Next Post >
Coronavirus exposes income-driven health inequality [PODCAST]

ADVERTISEMENT

More by Austin A. Barr

  • AI hype could undermine its real potential in health care

    Austin A. Barr

Related Posts

  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • COVID-19 and the Tuskegee syphilis study

    Bintou Diarra
  • Major medical groups back mandatory COVID vaccine for health care workers

    Molly Walker
  • How to get patients vaccinated against COVID-19 [PODCAST]

    The Podcast by KevinMD
  • State sanctioned executions in the age of COVID-19

    Kasey Johnson, DO
  • A patient’s COVID-19 reflections

    Michele Luckenbaugh

More in Conditions

  • Why peer support can save lives in high-pressure medical careers

    Maire Daugharty, MD
  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Why specialist pain clinics and addiction treatment services require strong primary care

    Olumuyiwa Bamgbade, MD
  • What a childhood stroke taught me about the future of neurosurgery and the promise of vagus nerve stimulation

    William J. Bannon IV
  • Facing terminal cancer as a doctor and mother

    Kelly Curtin-Hallinan, DO
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Life’s detours may be blessings in disguise

      Osmund Agbo, MD | Physician
    • Inside the heart of internal medicine: Why we stay

      Ryan Nadelson, MD | Physician
    • The quiet grief behind hospital walls

      Aaron Grubner, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • Bundled payments in Medicare: Will fixed pricing reshape surgery costs?

      AMA Committee on Economics and Quality in Medicine, Medical Student Section | Policy
    • How Project ECHO is fighting physician isolation and transforming medical education [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Life’s detours may be blessings in disguise

      Osmund Agbo, MD | Physician
    • Inside the heart of internal medicine: Why we stay

      Ryan Nadelson, MD | Physician
    • The quiet grief behind hospital walls

      Aaron Grubner, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • Bundled payments in Medicare: Will fixed pricing reshape surgery costs?

      AMA Committee on Economics and Quality in Medicine, Medical Student Section | Policy
    • How Project ECHO is fighting physician isolation and transforming medical education [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...